These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9327899)

  • 21. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.
    Yáñez M; Fraiz N; Cano E; Orallo F
    Eur J Pharmacol; 2006 Aug; 542(1-3):54-60. PubMed ID: 16828740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical chemistry of monoamine oxidase.
    Glover V; Sandler M
    Cell Biochem Funct; 1986 Apr; 4(2):89-97. PubMed ID: 3486724
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuropsychopharmacology of monoamines and their regulatory enzymes.
    Lipton MA
    Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941
    [No Abstract]   [Full Text] [Related]  

  • 24. Monoamine oxidase activity of blood platelets and their ability to store 5-hydroxytryptamine in some mental deficiencies.
    Paasonen MK; Solatunturi E; Kivalo E
    Psychopharmacologia; 1964 Jul; 6(2):120-4. PubMed ID: 4221126
    [No Abstract]   [Full Text] [Related]  

  • 25. Platelets as models: use and limitations.
    Pletscher A
    Experientia; 1988 Feb; 44(2):152-5. PubMed ID: 2831077
    [No Abstract]   [Full Text] [Related]  

  • 26. Normetanephrine and metanephrine oxidized by both types of monoamine oxidase.
    Suzuki O; Matsumoto T
    Experientia; 1985 May; 41(5):634-6. PubMed ID: 3996536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biogenic amine metabolite patterns in the urine of monoamine oxidase A-deficient patients. A possible tool for diagnosis.
    Abeling NG; van Gennip AH; Overmars H; van Oost BA; Brunner HG
    J Inherit Metab Dis; 1994; 17(3):339-41. PubMed ID: 7807947
    [No Abstract]   [Full Text] [Related]  

  • 28. Expression of functional human monoamine oxidase A and B cDNAs in mammalian cells.
    Lan NC; Chen CH; Shih JC
    J Neurochem; 1989 May; 52(5):1652-4. PubMed ID: 2496202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet and plasma amine oxidase inhibition and urinary amine excretion changes during phenelzine treatment.
    Murphy DL; Brand E; Goldman T; Baker M; Wright C; van Kammen D; Gordon E
    J Nerv Ment Dis; 1977 Feb; 164(2):129-34. PubMed ID: 836485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychiatric genetics. Misbehaving monoamine oxidase gene.
    Craig I
    Curr Biol; 1994 Feb; 4(2):175-7. PubMed ID: 7953526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No association between Parkinson's disease and monoamine oxidase A and B gene polymorphisms.
    Nanko S; Ueki A; Hattori M
    Neurosci Lett; 1996 Feb; 204(1-2):125-7. PubMed ID: 8929994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electron-microscopic study of MAOB-containing structures in the nucleus accumbens shell: using MAOA-deficient transgenic mice.
    Ikemoto K; Kitahama K; Maeda T; Tokunaga Y; Valatx JL; De Maeyer E; Seif I
    Brain Res; 1997 Oct; 771(1):163-6. PubMed ID: 9383021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two types of monoamine liberation by chlorinated aralkylamines.
    Pletscher A; Da Prada M; Bartholini G; Burkard WP; Bruderer H
    Life Sci; 1965 Dec; 4(23):2301-8. PubMed ID: 5880882
    [No Abstract]   [Full Text] [Related]  

  • 34. Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period.
    Cases O; Vitalis T; Seif I; De Maeyer E; Sotelo C; Gaspar P
    Neuron; 1996 Feb; 16(2):297-307. PubMed ID: 8789945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients.
    Mészáros Z; Borcsiczky D; Máté M; Tarcali J; Tekes K; Magyar K
    J Neural Transm Suppl; 1998; 52():79-85. PubMed ID: 9564610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From A to B to serendipity: the story of a monoamine oxidase knockout.
    Tabakoff B
    Alcohol Clin Exp Res; 1996 Feb; 20(1):195-6. PubMed ID: 8651454
    [No Abstract]   [Full Text] [Related]  

  • 37. Aggression in mice and men?
    Rose SP
    Science; 1995 Oct; 270(5235):362-4. PubMed ID: 7569986
    [No Abstract]   [Full Text] [Related]  

  • 38. MAOA deficiency and abnormal behaviour: perspectives on an association.
    Brunner HG
    Ciba Found Symp; 1996; 194():155-64; discussion 164-7. PubMed ID: 8862875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoamine oxidase and behaviour.
    Brunner HG
    Ann Med; 1995 Aug; 27(4):431-2. PubMed ID: 8519502
    [No Abstract]   [Full Text] [Related]  

  • 40. Are MAO-A deficiency states in the general population and in putative high-risk populations highly uncommon?
    Murphy DL; Sims K; Eisenhofer G; Greenberg BD; George T; Berlin F; Zametkin A; Ernst M; Breakefield XO
    J Neural Transm Suppl; 1998; 52():29-38. PubMed ID: 9564605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.